FISCHER LAURENT enters LYCIA THERAPEUTICS, INC. with 33.27K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/22/2026ACC: 0001379344-26-000009
33.27K
Baseline shares
100% direct
33.27K
Direct ownership
1 position
26.61K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned33.27K
Total
33.27K direct33.27K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 33.27K | Direct |
| Total | 33.27K | 33.27K direct |
Derivative Holdings2
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
13.31K
Shares owned
N/A
Exercise price
3.70
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
13.31K
Shares owned
N/A
Exercise price
2.44
Expiration
—
Exercise window
—
Total
Underlying
26.61K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 3.70 | — | — | 13.31K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 2.44 | — | — | 13.31K | N/A |
| Total | 26.61K | 0.00 | ||||